contract manufacturing
The triangular factors related to outsourcing mAbs projects
With emerging biotechs playing a critical part in developing new drugs, Merck attempts to understand the interactions between parties when manufacturing monoclonal antibodies (mAbs). Read more
Contractual obligations: Key thoughts on contract manufacturing
EPM speaks to a number of key players in contract manufacturing to get their thoughts on the sector’s changing landscape. Read more
Straight to the source of contract manufacturing
What benefits does an embedded CDMO model bring and how Pfizer CentreOne operates within one of the world’s premier biopharmaceutical companies. Read more
Tubilux selects TraceLink’s solutions to comply with EU FMD
Pharmaceutical contract manufacturer, Tubilux, has selected TraceLink’s serialisation solutions to help its customers with EU falsified medicines directive (EU FMD) compliance. Read more
Catalent working to re-start production at French facility
Catalent’s softgel plant in Beinheim, France received notification from l’Agence National de Sécurité du Médicament et des produits de santé (ANSM) requiring the suspension of manufacturing within the site Read more
Sterile inspection success for Symbiosis
Injectables manufacturer Symbiosis Pharmaceutical Services has reported a successful Medicines and Healthcare products Regulatory Agency (MHRA) inspection. Read more
DPT enhances semi-solid and liquid operations in San Antonio
Semi-solid and liquid specialist DPT Laboratories has implemented a new order execution strategy that will enhance its operations in San Antonio, Texas. Read more
Indicia Production welcomes investment from Amundi PEF
CMO Indicia Production has announced that Amundi Private Equity Funds has acquired a stake in its capital. Read more
Novasep signs deals with Allied Laboratories and AR Brown to extend presence in Japan
Novasep, a supplier of services and technologies for the life sciences and chemical industries, is expanding its presence in Asia by signing two partnership agreements for the Japanese market. Read more
Recipharm hires chief strategy officer
CDMO Recipharm has appointed Jean-François Hilaire to the new position of chief strategy officer, joining Recipharm’s group management team. Read more
Novasep’s plant extension for commercial ADC payload manufacturing now commissioned
Novasep’s €4 million (£3.3/$5.5 million) investment to expand its highly potent active pharmaceutical ingredients (HPAPIs) manufacturing capabilities at its Le Mans facility in France has reached fruition. The plant extension has been fully... Read more
Penn Pharma voted Best in Class for Innovation
Pharmaceutical manufacturer Penn Pharma received a prestigious accolade at the annual CMO Leadership Awards, in New York, US, winning Best in Class for Innovation. Based in Tredegar in Blaenau Gwent, South Wales, UK, Penn Pharma delivers... Read more
Vetter Pharma implements serialisation to support track and trace efforts
Significant progress has been made with Vetter Pharma’s product packaging solution, which is designed to support the prevention of product counterfeiting. This development is in response to expanded requirements by official regulatory agencies... Read more
Latest hires prepare Quay Pharma for next stage of growth
CDMO Quay Pharma has made a number of key appointments as the company continues to experience strong demand both at home and overseas across its entire range of specialist services. Read more
UK high capacity manufacturing facility ready for action following successful validation
Aesica’s High Capacity Manufacturing facility has been validated for commercial production; $45 million (€32.4/£27 million) has been invested at its Queenborough, UK, site. Read more
Capsule Technology Delivers Dual Dosing for High Potency Products
Penn Pharma had a fully contained Bosch GKF HiProtect combination dose capsule filler installed at its new facility in South Wales, UK, to enable the development and manufacture of capsules containing highly potent compounds. Read more
Cobra Biologics and BioCancell to Manufacture Promising Cancer Therapy Drug
Cobra Biologics and BioCancell have announced an agreement to manufacture BioCancell’s BC-821 cancer drug for clinical trials. Read more
Phillips-Medisize Reaches 50th Year Milestone
Matt Jennings, President and CEO of Phillips-Medisize Corporation, has announced that 2014 represents the company’s 50th year of continuous operation. Read more
Hapten Sciences and Particle Sciences Partner to Bring Poison Ivy Product into Clinical Trials
Drug delivery CDMO Particle Sciences has partnered with Hapten Sciences to progress Hapten’s lead product into the clinic. The product is a vaccine developed to lessen or eliminate contact dermatitis from poison ivy, oak and sumac exposure. Read more
Penn Pharma Celebrates Three Accident Free Years
Pharmaceutical manufacturer Penn Pharma has reached a significant safety milestone this month, operating for three years without experiencing a reportable accident at its facility in Gwent, South Wales, UK. The new contained manufacturing facility... Read more
